PHVS

Pharvaris N.V. Ordinary Shares

27.05

USD

PHVS Earnings Reports

Positive Surprise Ratio

PHVS beat 12 of 20 last estimates.

60%

Next Report

Date of Next Report

Apr 06, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.63

Implied change from Q3 25 (Revenue/ EPS)

+6.78%

Implied change from Q4 24 (Revenue/ EPS)

-1.56%

Pharvaris N.V. Ordinary Shares earnings per share and revenue

On Nov 12, 2025, PHVS reported earnings of -0.59 USD per share (EPS) for Q3 25, beating the estimate of -0.68 USD, resulting in a 12.28% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.01% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.63 USD, with revenue projected to reach -- USD, implying an increase of 6.78% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Pharvaris N.V. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Pharvaris N.V. Ordinary Shares reported EPS of -$0.59, beating estimates by 12.28%, and revenue of $0.00, 0% as expectations.

How did the market react to Pharvaris N.V. Ordinary Shares's Q3 2025 earnings?

The stock price moved up 7.01%, changed from $24.12 before the earnings release to $25.81 the day after.

When is Pharvaris N.V. Ordinary Shares expected to report next?

The next earning report is scheduled for Apr 06, 2026.

What are the forecasts for Pharvaris N.V. Ordinary Shares's next earnings report?

Based on 12 analysts, Pharvaris N.V. Ordinary Shares is expected to report EPS of -$0.63 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.